Crossmark

Sex disparity in the management and outcomes of dyslipidemia of diabetic patients in the Arabian Gulf: findings from the CEPHEUS study

Crossref DOI link: https://doi.org/10.1186/s12944-018-0667-y

Published Online: 2018-02-05

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Al-Zakwani, Ibrahim

Al-Mahruqi, Fatma

Al-Rasadi, Khalid

Shehab, Abdullah

Al Mahmeed, Wael

Arafah, Mohammed

Al-Hinai, Ali T.

Al Tamimi, Omer

Al Awadhi, Mahmoud

Santos, Raul D.
Funding

Funding for this research was provided by:

AstraZeneca
More Information

Article History

Received: 3 November 2017

Accepted: 22 January 2018

First Online: 5 February 2018

Ethics approval and consent to participate

: This study complied with the Declaration of Helsinki. The study had approval from the internal review bodies/ethics committees of each participating institution in the each of the Arabian Gulf countries. Informed written consent was obtained from all patients enrolled in the study.

: Not applicable.

: RDS has received honoraria related to consulting, research and or speaker activities from: Amgen, Astra Zeneca, Biolab, Boehringer-Ingleheim, Eli-Lilly, Kowa, Merck, Pfizer, Sanofi/Regeneron and Procaps. The other authors disclose that they have no significant relationships with or financial interests in any commercial companies related to this study or article.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.